Bioharvest Sciences Stock Buy Hold or Sell Recommendation

CNVCF Stock  USD 5.13  0.26  4.82%   
Assuming the 90 days horizon and your above-average risk tolerance, our recommendation regarding Bioharvest Sciences is 'Strong Sell'. Macroaxis provides Bioharvest Sciences buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding CNVCF positions.
  
Check out Bioharvest Sciences Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool.
Note, we conduct extensive research on individual companies such as Bioharvest and provide practical buy, sell, or hold advice based on investors' constraints. Bioharvest Sciences. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.

Execute Bioharvest Sciences Buy or Sell Advice

The Bioharvest recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Bioharvest Sciences. Macroaxis does not own or have any residual interests in Bioharvest Sciences or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Bioharvest Sciences' advice using the current market data and latest reported fundamentals.

Time Horizon

Risk Tolerance

Execute Advice
Sell Bioharvest SciencesBuy Bioharvest Sciences
Strong Sell

Market Performance

InsignificantDetails

Volatility

Slightly riskyDetails

Hype Condition

StaleDetails

Current Valuation

OvervaluedDetails

Odds Of Distress

LowDetails

Economic Sensitivity

Slowly supersedes the marketDetails

Analyst Consensus

Not AvailableDetails

Reporting Quality (M-Score)

UnavailableDetails
For the selected time horizon Bioharvest Sciences has a Mean Deviation of 1.78, Semi Deviation of 2.03, Standard Deviation of 2.73, Variance of 7.48, Downside Variance of 5.43 and Semi Variance of 4.12
We provide trade advice to complement the prevailing expert consensus on Bioharvest Sciences. Our dynamic recommendation engine uses a multidimensional algorithm to analyze the company's potential to grow using all technical and fundamental data available at the time. To make sure Bioharvest Sciences is not overpriced, please confirm all Bioharvest Sciences fundamentals, including its total debt, number of employees, and the relationship between the ebitda and book value per share . Given that Bioharvest Sciences has a shares owned by insiders of 35.15 %, we suggest you to validate Bioharvest Sciences market performance and probability of bankruptcy to ensure the company can sustain itself in the current economic cycle given your prevailing risk tolerance and investing horizon.

Bioharvest Sciences Trading Alerts and Improvement Suggestions

Bioharvest Sciences has accumulated 3.97 M in total debt with debt to equity ratio (D/E) of 1.62, which is about average as compared to similar companies. Bioharvest Sciences has a current ratio of 0.68, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist Bioharvest Sciences until it has trouble settling it off, either with new capital or with free cash flow. So, Bioharvest Sciences' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Bioharvest Sciences sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Bioharvest to invest in growth at high rates of return. When we think about Bioharvest Sciences' use of debt, we should always consider it together with cash and equity.
The entity reported the revenue of 2.1 M. Net Loss for the year was (9.83 M) with profit before overhead, payroll, taxes, and interest of 670 K.
Bioharvest Sciences has accumulated about 1.21 M in cash with (6.79 M) of positive cash flow from operations.
Roughly 35.0% of Bioharvest Sciences shares are held by company insiders

Bioharvest Sciences Returns Distribution Density

The distribution of Bioharvest Sciences' historical returns is an attempt to chart the uncertainty of Bioharvest Sciences' future price movements. The chart of the probability distribution of Bioharvest Sciences daily returns describes the distribution of returns around its average expected value. We use Bioharvest Sciences price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Bioharvest Sciences returns is essential to provide solid investment advice for Bioharvest Sciences.
Mean Return
0.14
Value At Risk
-4.19
Potential Upside
3.70
Standard Deviation
2.73
   Return Density   
       Distribution  
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Bioharvest Sciences historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.

Bioharvest Sciences Greeks

Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Bioharvest Sciences or Healthcare sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Bioharvest Sciences' price will be affected by overall otc stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Bioharvest otc's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α
Alpha over Dow Jones
0.11
β
Beta against Dow Jones0.21
σ
Overall volatility
2.86
Ir
Information ratio 0.02

Bioharvest Sciences Volatility Alert

Bioharvest Sciences currently demonstrates below-average downside deviation. It has Information Ratio of 0.02 and Jensen Alpha of 0.11. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Bioharvest Sciences' otc stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Bioharvest Sciences' otc stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.

Bioharvest Sciences Fundamentals Vs Peers

Comparing Bioharvest Sciences' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Bioharvest Sciences' direct or indirect competition across all of the common fundamentals between Bioharvest Sciences and the related equities. This way, we can detect undervalued stocks with similar characteristics as Bioharvest Sciences or determine the otc stocks which would be an excellent addition to an existing portfolio. Peer analysis of Bioharvest Sciences' fundamental indicators could also be used in its relative valuation, which is a method of valuing Bioharvest Sciences by comparing valuation metrics with those of similar companies.
    
 Better Than Average     
    
 Worse Than Average Compare Bioharvest Sciences to competition
FundamentalsBioharvest SciencesPeer Average
Return On Equity-63.64-0.31
Return On Asset-0.53-0.14
Profit Margin(2.69) %(1.27) %
Operating Margin(2.45) %(5.51) %
Current Valuation106.97 M16.62 B
Shares Outstanding460.72 M571.82 M
Shares Owned By Insiders35.15 %10.09 %
Price To Book91.96 X9.51 X
Price To Sales28.13 X11.42 X
Revenue2.1 M9.43 B
Gross Profit670 K27.38 B
EBITDA(8.63 M)3.9 B
Net Income(9.83 M)570.98 M
Cash And Equivalents1.21 M2.7 B
Total Debt3.97 M5.32 B
Debt To Equity1.62 %48.70 %
Current Ratio0.69 X2.16 X
Book Value Per Share(0.01) X1.93 K
Cash Flow From Operations(6.79 M)971.22 M
Earnings Per Share(0.01) X3.12 X
Number Of Employees618.84 K
Beta1.02-0.15
Market Capitalization75.88 M19.03 B
Total Asset10.21 M29.47 B
Z Score11.48.72
Net Asset10.21 M

Bioharvest Sciences Market Momentum

Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Bioharvest . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.

About Bioharvest Sciences Buy or Sell Advice

When is the right time to buy or sell Bioharvest Sciences? Buying financial instruments such as Bioharvest OTC Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.

Use Investing Ideas to Build Portfolios

In addition to having Bioharvest Sciences in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Investment Grade ETFs Thematic Idea Now

Investment Grade ETFs
Investment Grade ETFs Theme
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Investment Grade ETFs theme has 265 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Investment Grade ETFs Theme or any other thematic opportunities.
View All  Next Launch

Other Information on Investing in Bioharvest OTC Stock

Bioharvest Sciences financial ratios help investors to determine whether Bioharvest OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Bioharvest with respect to the benefits of owning Bioharvest Sciences security.